Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:34 PM UTC
| NCT Number | NCT05633654 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,514 participants |
| Active Locations | 185 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | July 15, 2026 (Yesterday) |
As of July 16, 2026: Clinical trial NCT05633654 is currently recruiting participants. This phase3 study for triple negative breast cancer is actively seeking new participants at 185 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05633654 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 185 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05633654 was last updated Yesterday (July 15, 2026). HelloStudys verifies this status automatically.